ASBP - Aspire Biopharma Holdings, Inc.
1.32
-0.150 -11.364%
Share volume: 278,082
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.47
-0.15
-0.10%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 1.941 K | |
| Cost of revenue | 0.000 | 1.057 K | |
| Gross profit | 0.000 | 884.000 | |
| inf% | |||
| Operating expenses | 15.337 M | 720.892 K | |
| Selling general and admin | 15.074 M | 512.993 K | |
| Research and development | 263.093 K | 207.899 K | |
| Total expenses | 15.556 M | 1.146 M | |
| -92.63% | |||
| Operating income | -15.556 M | -1.145 M | |
| Ebit | -15.651 M | -370.435 K | |
| Pretax income | -15.941 M | -1.850 M | |
| -88.39% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -15.941 M | -1.850 M | |
| 88.39% |